New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
AIM ImmunoTech Inc. (AIM) vs SeaStar Medical Holding Corporation (ICU)
- AIM ImmunoTech Inc. AIM 0.12 −7.69%
- SeaStar Medical Holding Corporation ICU 1.04 0.00%
AIM ImmunoTech Inc. and SeaStar Medical Holding Corporation are both Biotechnology companies. SeaStar Medical Holding Corporation is the larger, with a market value of $5.5M against $4.8M — 1.2× the size. SeaStar Medical Holding Corporation grew revenue faster over the last twelve months: 145.7% against −18.8%. SeaStar Medical Holding Corporation has the higher net margin (−678.2% vs −15,526.4%) and the higher return on invested capital (0.00% vs −5,687.5%). Across the 16 metrics below, SeaStar Medical Holding Corporation leads on 12 and AIM ImmunoTech Inc. on 4.
Valuation
Profitability
| Metric | AIM | ICU | Biotechnology median |
|---|---|---|---|
| Gross margin | 38.46% | 92.61% | 70.18% |
| Operating margin | (12,800.00%) | (692.52%) | 0.00% |
| Net margin | (15,526.37%) | (678.24%) | 0.00% |
| Free cash flow margin | (13,792.31%) | (610.72%) | 0.00% |
| Return on equity | (2,828.63%) | (246.11%) | (51.58%) |
| Return on assets | (185.36%) | (140.92%) | (45.91%) |
| Return on invested capital | (5,687.50%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack